Performant Healthcare Reports 29% Increase in Healthcare Revenue and Reduces Net Loss in Q1 2025 Results
Reuters
Jul 24
Performant Healthcare Reports 29% Increase in Healthcare Revenue and Reduces Net Loss in Q1 2025 Results
Performant Healthcare Inc. announced its first-quarter financial results, surpassing expectations in both revenue and profitability. The company reported solid growth, especially in its commercial healthcare segment, with 13 new commercial programs estimated to contribute between $4.5 million and $5.0 million in annualized revenue. Performant's CEO, Simeon Kohl, highlighted the robustness of the business model and its commitment to reducing waste in the healthcare system. The company has adjusted its guidance for 2025, projecting healthcare revenues between $133 million and $135 million, with an adjusted EBITDA forecast of $9 million to $10 million. This optimistic outlook follows the successful execution of its strategy to focus solely on healthcare since 2021. Performant continues to see strong momentum with a growing pipeline and backlog of new contract awards.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Performant Healthcare Inc. published the original content used to generate this news brief on July 24, 2025, and is solely responsible for the information contained therein.
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.